Fig. 2From: A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquineArithmetic mean (SD) plasma concentration time profiles for KAF156 according to time and treatment group. Inset, first 24 h after dosing. Solid lines with open circles represent the KAF156 concentrations when given as monotherapy and dashed lines with cross marks represent KAF156 concentrations when given in combination with PPQBack to article page